Hepatic arterial anatomy for right liver procurement from living donors
Henkie P. Tan, Amadeo Marcos – 6 January 2004
Serum phosphate is not a reliable early predictor of outcome in paracetamol induced hepatotoxicity
Khee Lim Ng, J.S. Davidson, Andrew J. Bathgate – 6 January 2004
Is minimal hepatic encephalopathy completely reversible following liver transplantation?
Christopher Rose, Rajiv Jalan – 6 January 2004
A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone‐maintained liver transplant recipients
Robert M. Weinrieb, Rebecca Barnett, Kevin G. Lynch, Maria DePiano, Alfred Atanda, Kim M. Olthoff – 6 January 2004 – Approximately 85% of patients receiving methadone maintenance therapy (MMT) for opiate dependence in the United States are infected with hepatitis C virus (HCV). MMT is significantly underrepresented in most liver transplant programs, but the number of patients receiving MMT is increasing and few data are available to guide treatment.
Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis
Costas H. Kefalas, Natalie G.B. Murray, James J. Aguanno, William D. Dockery, Jeffrey S. Weinstein, Katherine Anderson, Goran B. Klintmalm – 6 January 2004 – Hypocalcemia in patients with cirrhosis may be due to a number of causes. We noted a relationship between injection with gadodiamide, a particular gadolinium chelate, during magnetic resonance imaging of the liver and the development of a falsely low serum total calcium level in a patient with cirrhosis. A cross‐reference and retrospective chart review identified 10 additional patients in whom this phenomenon was noted.
TIPSS as therapeutic modality for umbilical hernia in patients with advanced liver disease
Jasmohan Singh Bajaj, Rajiv R. Varma – 6 January 2004
Liver transplantation and health‐related quality of life: Scoring differences between men and women
Terianne Cowling, Linda W. Jennings, Robert M. Goldstein, Edmund Q. Sanchez, Srinath Chinnakotla, Goran B. Klintmalm, Marlon F. Levy – 6 January 2004 – Orthotopic liver transplantation (OLT) is the treatment of choice for end‐stage liver disease of various etiologies. Its use, however, remains limited due to the scarcity of donor organs. Measures to assess health‐related quality of life (HRQOL) are increasingly being implemented to examine the efficacy of medical therapies involving scarce resources.
Volume regeneration after right liver donation
Shojiro Hata, Yasuhiko Sugawara, Yoji Kishi, Takashi Niiya, Junichi Kaneko, Keiji Sano, Hiroshi Imamura, Norihiro Kokudo, Masatoshi Makuuchi – 6 January 2004 – After right hepatectomy with the middle hepatic vein trunk for a graft, the venous outflow in segment IV is disturbed. There are limited data, however, regarding the effect of middle hepatic vein deprivation on liver regeneration or functional recovery.
Quantitative assessment of fibrinogen cross‐linking by ϵaminocaproic acid in patients with end‐stage liver disease
Thien Quach, Melissa Tippens, Fania Szlam, Rebecca Van Dyke, Jerrold H. Levy, Marie Csete – 6 January 2004 – Analysis of the effectiveness of antifibrinolytic therapy for liver transplant recipients is hampered by lack of quantitative assays for assessing drug effects. We adapted chemical engineering tools used in polymerization studies to quantify fibrinogen cross‐linking by plasma from liver transplant patients obtained before and after ϵaminocaproic acid (EACA) therapy.